Manabu Shirakawa

Dr. Manabu Shirakawa

Hyogo Medical University Hospital, Nishinomiya, Japan
orcid

Research Focus & Metrics

Academic Career Length

19Years (2008-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2016 in Neurologia medico-chirurgica
Verified
Journal Article
Open access
NHNagayasu Hiyama
Nagayasu Hiyama
SYShinichi Yoshimura
Shinichi Yoshimura
MSManabu Shirakawa
Manabu Shirakawa
KUKazutaka Uchida
Kazutaka Uchida
YOYoshiharu Oki
Yoshiharu Oki
KTKou Tokuda
Kou Tokuda
This study analyzed the efficacy and safety of the "drip, ship, and retrieve (DSR)" approach used to improve patient access to thrombectomy for acute stroke. The study participants were 45 patients who underwent thrombectomy following intravenous tissue plasminogen activator between September 2013 and August 2015. Patients were divided into two groups according to whether they were transferred from another hospital (DSR group; n = 33) or were brought in directly (Direct group; n = 12). The two groups were compared based on their baseline characteristics, time from stroke onset to reperfusion, outcome, and adverse events. There were no significant differences in baseline characteristics. Time from onset until admission to our facility was significantly shorter in the Direct group (56.9 min) than in the DSR group (163.5 min) (P <0.0001). Conversely, time from arrival at the hospital to arterial puncture was significantly shorter in the DSR group (25.0 min) than in the Direct group (109.5 min) (P <0.0001). Time from onset to reperfusion did not differ significantly between the groups. There was no significant difference in patient outcomes, with a modified Rankin scale score of 0-2 (44.8% in DSR group versus 48.7% in Direct group). Moreover, there was no difference in the incidence of adverse events. Despite the time required to transfer patients in the DSR group between hospitals, reducing the time from arrival until commencement of endovascular therapy meant that the time from onset to reperfusion was approximately equivalent to that of the Direct group. Time-saving measures need to be taken by both the transferring and receiving hospitals in DSR paradigm.

1 January 2008 in Neurologia medico-chirurgica
Verified
Journal Article
Closed access
MSManabu Shirakawa
Manabu Shirakawa
TNTatsuya Nishioka
Tatsuya Nishioka
KYKohsuke Yamashita
Kohsuke Yamashita
YMYukio Maeda
Yukio Maeda
NANorio Arita
Norio Arita
A 58-year-old man presented with a traumatic vertebro-vertebral arteriovenous fistula (VVAVF) after attempting suicide by thrusting scissors into his right anterior cervical region. Two months later he noticed weakness and numbness of the right upper extremity. Examination revealed bruit in the right neck, no cranial nerve palsy, and weakness of the right deltoid and biceps muscles. Hypalgesia and hypesthesia were noted in the right C5 and C6 dermatomes. Magnetic resonance imaging demonstrated a mass lesion on the right ventral aspect of the spinal canal from C2 to C7. Right vertebral artery angiography showed a pseudoaneurysm of the right vertebral artery and a high-flow arteriovenous fistula between the right vertebral artery and vein. The right vertebral artery was occluded with detachable coils because the fistula showed high blood flow and the right posterior inferior cerebellar artery was well opacified from the left vertebral artery. This procedure resulted in complete obliteration of the arteriovenous fistula. The preoperative motor and sensory symptoms improved. Endovascular treatment by coil embolization was effective in our patient with traumatic VVAVF.

1 October 2020 in American Journal of Neuroradiology
Verified
Journal Article
Closed access
PDF file
MBMikiya Beppu
Mikiya Beppu
MTM. Tsuji
M. Tsuji
FIF. Ishida
F. Ishida
MSManabu Shirakawa
Manabu Shirakawa
Hidenori SuzukiHidenori Suzuki
Hidenori Suzuki
SYShinichi Yoshimura
Shinichi Yoshimura
BACKGROUND AND PURPOSE: Knowledge about predictors of the outcome of flow-diverter treatment is limited. The aim of this study was to predict the angiographic occlusion status after flow-diverter treatment with computational fluid dynamics using porous media modeling for decision-making in the treatment of large wide-neck aneurysms. MATERIALS AND METHODS: A total of 27 patients treated with flow-diverter stents were retrospectively analyzed through computational fluid dynamics using pretreatment patient-specific 3D rotational angiography. These patients were classified into no-filling and contrast-filling groups based on the O’Kelly-Marotta scale. The patient characteristics, morphologic variables, and hemodynamic parameters were evaluated for understanding the outcomes of the flow-diverter treatment. RESULTS: The patient characteristics and morphologic variables were similar between the 2 groups. Flow velocity, wall shear stress, shear rate, modified aneurysmal inflow rate coefficient, and residual flow volume were significantly lower in the no-filling group. A novel parameter, called the normalized residual flow volume, was developed and defined as the residual flow volume normalized by the dome volume. The receiver operating characteristic curve analyses demonstrated that the normalized residual flow volume with an average flow velocity of ≥8.0 cm/s in the aneurysmal dome was the most effective in predicting the flow-diverter treatment outcomes. CONCLUSIONS: It was established in this study that the hemodynamic parameters could predict the angiographic occlusion status after flow-diverter treatment.

1 August 2023 in Stroke
Verified
Journal Article
Closed access
SNSatoshi Namitome
Satoshi Namitome
KUKazutaka Uchida
Kazutaka Uchida
SSSeigo Shindo
Seigo Shindo
SYShinichi Yoshimura
Shinichi Yoshimura
NSNobuyuki Sakai
Nobuyuki Sakai
FIfor the RESCUE-Japan LIMIT Investigators
for the RESCUE-Japan LIMIT Investigators
BACKGROUND: The increased risk of intracranial hemorrhage with multiple passes in endovascular therapy (EVT) for large vessel occlusion with a large ischemic core is a concern. We explored the effect of the number of EVT passes on patients in a randomized clinical trial. METHODS: This post hoc study was the secondary analysis of RESCUE-Japan LIMIT, which was a randomized clinical trial comparing EVT and medical treatment alone for large vessel occlusion with large ischemic core. We grouped patients according to the number of passes with successful reperfusion (modified Thrombolysis in Cerebral Infarction score, ≥2b) in 1, 2, and 3 to 7 passes and failed reperfusion (modified Thrombolysis in Cerebral Infarction score, 0–2a) after any pass in the EVT group, and these groups were compared with medical treatment group. The primary outcome was modified Rankin Scale score of 0 to 3 at 90 days. Secondary outcomes were improvement in National Institutes of Health Stroke Scale score of ≥8 at 48 hours, mortality at 90 days, symptomatic intracranial hemorrhage, and any intracranial hemorrhage within 48 hours. RESULTS: The number of patients who received EVT with successful reperfusion after 1, 2, and 3 to 7 passes and failed reperfusion were 44, 23, 19, and 14, respectively, and 102 received medical treatment alone. The adjusted odds ratios (95% CIs) for the primary outcome relative to medical treatment were 5.52 (2.23–14.28) after 1 pass, 6.45 (2.22–19.30) after 2 passes, 1.03 (0.15–4.48) after 3 to 7 passes, and 1.17 (0.16–5.37) if reperfusion failed. The adjusted odds ratios (95% CIs) for any intracranial hemorrhage within 48 hours relative to medical treatment were 1.88 (0.90–3.93) after 1 pass, 5.14 (1.97–14.72) after 2 passes, 3.00 (1.09–8.58) after 3 to 7 passes, and 6.16 (1.87–24.27) if reperfusion failed. CONCLUSIONS: The successful reperfusion within 2 passes was associated with better clinical outcomes. REGISTRATION: URL: https://www.clinicaltrials.gov ; Unique identifier: NCT03702413.

1 October 2021 in Journal of Stroke and Cerebrovascular Diseases
Verified
Journal Article
Closed access
MSManabu Shirakawa
Manabu Shirakawa
HMHidetoshi Matsukawa
Hidetoshi Matsukawa
NSNobuyuki Sakai
Nobuyuki Sakai
HYHiroshi Yamagami
Hiroshi Yamagami
KTKanta Tanaka
Kanta Tanaka
SYShinichi Yoshimura
Shinichi Yoshimura

1 May 2019 in World Neurosurgery
Verified
Journal Article
Closed access
MSManabu Shirakawa
Manabu Shirakawa
SYShinichi Yoshimura
Shinichi Yoshimura
KUKazutaka Uchida
Kazutaka Uchida
KYKiyofumi Yamada
Kiyofumi Yamada
DSDaisuke Sakamoto
Daisuke Sakamoto
RIReiichi Ishikura
Reiichi Ishikura